Illexcor Therapeutics
PrivateLast Round
Seed Round
Apr 15, 2026
Total Funding Raised
$5.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Illexcor Therapeutics operates in Healthcare & Life Sciences and is based in Richmond, Virginia. Its latest recorded funding round was a Seed round in March 2025.
Illexcor Therapeutics is a biotechnology company that develops oral therapies for sickle cell disease and other hematologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illexcor Therapeutics Comparables
Compare Illexcor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardurion Pharmaceuticals | 77% | |
| Pfizer | 76% | |
| Fulcrum Therapeutics, Inc. | 74% |
For institutional investors. Book with your work email.
Illexcor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 15, 2026 | ||||
| Seed | Mar 12, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Illexcor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Zynext Ventures | Seed |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
$13M raised in Seed Round.
- Mar 12, 2025
Seed round led by Zynext Ventures.
For institutional investors. Book with your work email.
Illexcor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Illexcor Therapeutics's valuation, stock price, and market status.
Is Illexcor Therapeutics a public or private company?
Illexcor Therapeutics is a private company.
What is the current stock price of Illexcor Therapeutics?
Illexcor Therapeutics is a private company, so its shares have no public market price. Caplight tracks Illexcor Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Illexcor Therapeutics worth (valuation)?
Valuation information for Illexcor Therapeutics is not publicly available.
Can I buy Illexcor Therapeutics stock?
Illexcor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Illexcor Therapeutics's last funding round?
Illexcor Therapeutics's most recent funding round was Seed Round on April 15, 2026.
Who are the main investors in Illexcor Therapeutics?
Key investors in Illexcor Therapeutics include Zynext Ventures.
Will Illexcor Therapeutics IPO soon?
No public IPO plans have been announced for Illexcor Therapeutics.
How can I track Illexcor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Illexcor Therapeutics's shares on secondary markets.